Ownership

Jay Lichter - Director, 10%+ Owner at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director, 10%+ Owner
Stock Symbol: JANX on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Jay Lichter - trading volume in the past year for Janux Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+850K	36.2%	$5.87	+$4.99M
Sells	-1.5M	63.8%	$54.75	-$82.1M
Net	-650K	-27.7%		-$77.1M

Holdings reported by Jay Lichter for Janux Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	3.34M	$183M	$54.75	Jun 26, 2024	By Avalon BioVentures SPV I, L.P.
Common Stock	3.27M	$179M	$54.75	Jun 26, 2024	By Avalon Ventures XI, L.P.
Common Stock	634K	$34.7M	$54.75	Jun 26, 2024	By Avalon BioVentures I, LP
Common Stock	7.08K	$388K	$54.75	Jun 26, 2024	Direct
Stock Option (right to buy)	8.35K			Jun 26, 2024	Direct	Common Stock

Transactions reported by Jay Lichter for Janux Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.